BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3166500)

  • 1. [Phenotypic analysis of acute megakaryoblastic leukemia following myelodysplastic syndrome. Evidence for leukemic cells reacting with 3A1 (CD7) and A2B5 monoclonal antibodies].
    Uike N; Kozuru M; Takeichi N; Shibata K; Akiyoshi T; Anami K; Shibuya T; Niho Y; Oku K; Takeshita M
    Rinsho Ketsueki; 1988 Jun; 29(6):889-95. PubMed ID: 3166500
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of myelodysplastic syndrome with abnormal chromosome t (3;4), proliferation of megakaryocytes and myelofibrosis, transition to overt leukemia].
    Nehashi Y; Iwabuchi H; Tsuda A; Kawanishi Y; Tauchi T; Kawaguchi M; Oyashiki K; Sotoyama K
    Nihon Naika Gakkai Zasshi; 1991 May; 80(5):759-60. PubMed ID: 1875112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analytical study on leukemic megakaryocytic cells using simultaneous demonstration of membrane antigen with monoclonal antibodies and peroxidase cytochemistry at ultrastructural level].
    Enomoto Y; Watanabe Y
    Rinsho Ketsueki; 1988 Aug; 29(8):1150-62. PubMed ID: 2849691
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
    Zipursky A; Christensen H; De Harven E
    Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
    Suda J; Eguchi M
    Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
    [No Abstract]   [Full Text] [Related]  

  • 8. Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia.
    Breton-Gorius J; Villeval JL; Kieffer N; Mitjavila MT; Guichard J; Vainchenker W
    Blood Cells; 1989; 15(1):259-77. PubMed ID: 2649184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic changes in the megakaryocyte-platelet lineage.
    Stenberg PE
    Scanning Microsc; 1988 Dec; 2(4):2117-27. PubMed ID: 3238385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndrome with transformation to AML-M7 in a 46,XX male patient.
    Lau LC; Lim P; Lee LH; Hwang W; Lui WO; Chong YY
    Cancer Genet Cytogenet; 2002 Jul; 136(2):153-4. PubMed ID: 12237243
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.
    Wang SA; Hasserjian RP
    Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of acute megakaryoblastic leukemia].
    Koike T; Aoki S; Maruyama S; Shibata A
    Rinsho Ketsueki; 1988 Aug; 29(8):1163-9. PubMed ID: 3204667
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders. A morphometric study.
    Thiele J; Krech R; Wienhold S; Simon KG; Zankovich R; Fischer R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 54(2):89-97. PubMed ID: 2892311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression.
    Matsuo H; Wakita T; Hiramatsu H; Ohmori K; Kodama K; Nakatani K; Kamikubo Y; Iwamoto S; Kondo T; Takaori-Kondo A; Takita J; Tomizawa D; Taga T; Adachi S
    Br J Haematol; 2021 Jan; 192(1):e7-e11. PubMed ID: 33095915
    [No Abstract]   [Full Text] [Related]  

  • 15. Micromegakaryocytic transformation of myelofibrosis with myeloid metaplasia.
    Rosangela I; Pecci A; Formisano R
    Haematologica; 2000 Jan; 85(1):98-9. PubMed ID: 10629600
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
    Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
    Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemophagocytosis by leukemic blasts in a case of acute megakaryoblastic leukemia with t(16;21)(p11;q22).
    Imashuku S; Hibi S; Kuriyama K; Todo S
    Int J Hematol; 1999 Jul; 70(1):36-9. PubMed ID: 10446493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple factors in the transformation of essential thrombocythemia to acute leukemia or myelodysplastic syndrome.
    Liu TC; Suri R
    Blood; 1998 Aug; 92(4):1465-6. PubMed ID: 9694744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Megakaryoblastic leukemia--theories and controversies].
    Nowakowski A
    Acta Haematol Pol; 1987; 18(1-2):83-8. PubMed ID: 3324609
    [No Abstract]   [Full Text] [Related]  

  • 20. [Werner's syndrome developing acute megakaryoblastic leukemia with der(1;7)].
    Yamada T; Tsurumi H; Murakami N; Moriwaki H; Muto Y; Yamada T
    Rinsho Ketsueki; 1997 Jan; 38(1):28-32. PubMed ID: 9028158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.